Coverage
-
August 03, 2021
A Pennsylvania federal court has given its final approval to an $8.5 million settlement between Trevena Inc. and investors who say the biopharmaceutical company misled them about federal approvals for a morphine alternative.
2 other articles on this case.
View all »